HomeLifestyleMediaCassava Sciences (SAVA) Alzheimer's Drug Shows Positive Results

Cassava Sciences (SAVA) Alzheimer's Drug Shows Positive Results

Cassava Sciences (SAVA) is a clinical-stage biotechnology company, engaged in the detection and treatments of neurodegenerative diseases, such as Alzheimer's disease. George Tsilis joins Alex Coffey and Jenny Horne to discuss SAVA as the stock is up nearly 60% from its 52-week low. He talks about how SAVA's Alzheimer's drug Simufilam showed results that it slowed cognitive decline in a small Alzheimer’s disease trial. Tune in to find out more about the stock market today.

ON AIR
12:00 am
Fast Market
replay
ON AIR
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now